scispace - formally typeset
A

Antonis S. Zervos

Researcher at University of Central Florida

Publications -  40
Citations -  9362

Antonis S. Zervos is an academic researcher from University of Central Florida. The author has contributed to research in topics: Inhibitor of apoptosis & Protease. The author has an hindex of 27, co-authored 37 publications receiving 8793 citations. Previous affiliations of Antonis S. Zervos include Thomas Jefferson University & Harvard University.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites

TL;DR: A novel human protein that specifically interacts with Max, Mxi1, contains a bHLH-Zip motif that is simillar to that found in Myc family proteins, which is consistent with a model in which Mxi2-Max heterodimers indirectly inhibit Myc function in two ways.
Journal ArticleDOI

Identification of Omi/HtrA2 as a Mitochondrial Apoptotic Serine Protease That Disrupts Inhibitor of Apoptosis Protein-Caspase Interaction

TL;DR: The results provide clear evidence for the involvement of a mitochondrial serine protease in the apoptotic pathway, emphasizing the critical role of the mitochondria in cell death.
Journal ArticleDOI

Specific interaction of type I receptors of the TGF-beta family with the immunophilin FKBP-12

TL;DR: The specific interaction between the type I receptors and FKBP-12 suggests that FK BP-12 may play a role in type I receptor-mediated signaling.
Journal ArticleDOI

Resveratrol inhibits Src and Stat3 signaling and induces the apoptosis of malignant cells containing activated Stat3 protein

TL;DR: This study is among the first to identify Src-Stat3 signaling as a target of resveratrol, further defining the mechanism of antitumor cell activity of res veratrol and raising its potential application in tumors with an activated Stat3 profile.